Research on semaglutide (Ozempic, Wegovy) during breastfeeding is limited
Feldman and colleagues in 2025, recapitulated these findingsin patients 40 years or older with T2D and active COPD, GLP-1RAs and SGLT-2 inhibitors, but not DDP-4 inhibitors, reduced the risk of moderate or severe COPD exacerbations
Once confirmed, we administer the infusion slowly over 30 minutes , allowing for optimal absorption while minimizing side effects
We start with your health history, your current medications, your labs, and what you are actually trying to accomplish
Is it consistent with what you expect based on the label ingredients
adults 18 and older who had either obesity or overweight with at least one of the following medical conditions: heart disease, high blood pressure, high cholesterol, or obstructive sleep apnea